Your browser doesn't support javascript.
loading
Synthesis of rod-like CeO2 nanoparticles and their application to catalyze the luminal-O2 chemiluminescence reaction used in the determination of oxcarbazepine and ascorbic acid.
Iranifam, Mortaza; Haggi, Asghar; Akhteh, Hossein; Amini, Mojtaba; Al Lawati, Haider A J.
Afiliação
  • Iranifam M; Department of Chemistry, Faculty of Science, University of Maragheh, P.O. Box: 55181-83111, Maragheh, Iran. Mortezairanifam@yahoo.com.
  • Haggi A; Department of Chemistry, Faculty of Science, University of Maragheh, P.O. Box: 55181-83111, Maragheh, Iran.
  • Akhteh H; Department of Chemistry, Faculty of Science, University of Maragheh, P.O. Box: 55181-83111, Maragheh, Iran.
  • Amini M; Department of Chemistry, Faculty of Science, University of Maragheh, P.O. Box: 55181-83111, Maragheh, Iran.
  • Al Lawati HAJ; Department of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Anal Sci ; 38(5): 787-793, 2022 May.
Article em En | MEDLINE | ID: mdl-35298793
Rod-like CeO2 nanoparticles (NPs) were produced by the quick precipitation approach and employed as a catalyzer to increase the chemiluminescence (CL) intensity of the luminol-O2 reaction. The transmission electron microscopy (TEM) images of the CeO2 NPs showed that rod-like particles with the length and diameter about 15 nm and 5 nm, respectively, were produced. Furthermore, pharmaceuticals including oxcarbazepine (OXP) and ascorbic acid (AA) showed an inhibitory effect against the CL intensity such that the more concentration of the pharmaceuticals, the less was the CL intensity. Therefore, the new CeO2 NPs-luminol-O2 CL reaction was developed to determine OXP and AA in the pharmaceutical formulations. It is the first CL method established for the quantification of OXP. The linear dynamic range of this method for OXP was from 6.0 × 10-7 to 6.0 × 10-5 mol L-1 and for AA from 1.0 × 10-6 to 1.0 × 10-4 mol L-1.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Luminol Idioma: En Revista: Anal Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Luminol Idioma: En Revista: Anal Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Suíça